CClinicalTrials.gg
CompletedNCT00814411GCFPUpdated Dec 24, 2008

A Trial of Group Versus Individual Family Planning Counseling in Ghana

A Phase 3 interventional study of group family planning counseling and Individual family planning counseling in Contraception, sponsored by Johns Hopkins Bloomberg School of Public Health. Completed at 3 sites in 2 countries. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2008-12-24.

Sponsored by Johns Hopkins Bloomberg School of Public Health · Phase 3, Interventional, and Prevention

Phase
Phase 3
Study type
Interventional
Enrollment
648
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

This study uses a randomized, noninferiority design to determine whether group family planning counseling is as effective as individual family planning counseling among gynecological patients with unmet need at two teaching hospitals in Ghana.

02

Conditions studied

  • Contraception

Keywords

  • contraception
  • noninferiority
  • intention
  • family planning counseling
  • post abortion care
  • Family planning intention among women with unmet need
03

In context

Lead sponsor

Johns Hopkins Bloomberg School of Public Health is the lead sponsor of 364 studies on the registry; 41 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 3 (60%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • 18 years of age and older
  • fertile
  • desires to delay pregnancy for at least 12 months

Exclusion criteria

Exclusion Criteria:

-

05

Study design

Phase
Phase 3
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
648 participants (actual)

Study arms

  • Experimental
    Group Counseling

    Group family planning counseling

    Behavioral: group family planning counseling

  • Active comparator
    Individual Counseling

    Individual family planning counseling with gynecological patients who have unmet need

    Behavioral: Individual family planning counseling

Interventions

  • Behavioralgroup family planning counseling

    group family planning counseling for gynecological patients with unmet need

  • BehavioralIndividual family planning counseling

    Individual family planning counseling with gynecological patients - the current standard of care

06

What researchers measure

Primary outcomes

  1. Contraceptive Intention

    Time frame: Follow-up

Secondary outcomes

  1. Modern contraceptive method knowledge

    Time frame: baseline and follow-up

07

Study locations

3 sites
  • Johns Hopkins Bloomberg School of Public Health
    Baltimore, Maryland 21218, United States
  • Komfo Anokye Teaching Hospital
    Kumasi, Ashanti, Ghana
  • Korle Bu Teaching Hospital
    Accra, Greater Accra, Ghana
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 24, 2008, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00814411
Lead sponsor
Johns Hopkins Bloomberg School of Public Health
Collaborators
Bill and Melinda Gates Foundation, Kwame Nkrumah University of Science and Technology
First posted
Dec 24, 2008
Start date
Jun 2008
Primary completion
Jul 2008
Completion
Jul 2008
Last update
Dec 24, 2008

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2008. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion